These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 30159809

  • 1. Platelet-Derived Microparticles: A New Index of Monitoring Platelet Activation and Inflammation in Kawasaki Disease.
    Jin J, Wang J, Lu Y, Fan Z, Huang N, Ma L, Yu H.
    Indian J Pediatr; 2019 Mar; 86(3):250-255. PubMed ID: 30159809
    [Abstract] [Full Text] [Related]

  • 2. The Usefulness of Platelet-derived Microparticle as Biomarker of Antiplatelet Therapy in Kawasaki Disease.
    Kim HJ, Choi EH, Lim YJ, Kil HR.
    J Korean Med Sci; 2017 Jul; 32(7):1147-1153. PubMed ID: 28581272
    [Abstract] [Full Text] [Related]

  • 3. Platelet activation dynamics evaluated using platelet-derived microparticles in Kawasaki disease.
    Yahata T, Suzuki C, Yoshioka A, Hamaoka A, Ikeda K.
    Circ J; 2014 Jul; 78(1):188-93. PubMed ID: 24152721
    [Abstract] [Full Text] [Related]

  • 4. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].
    Peng Q, Wu Q, Chen CH, Hong H, Zhang LY.
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):208-10. PubMed ID: 16787593
    [Abstract] [Full Text] [Related]

  • 5. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.
    Ye Q, Shao WX, Shang SQ, Zhang T, Hu J, Zhang CC.
    Arthritis Rheumatol; 2015 Jul; 67(7):1943-50. PubMed ID: 25778686
    [Abstract] [Full Text] [Related]

  • 6. TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease.
    Hu P, Jiang GM, Wu Y, Huang BY, Liu SY, Zhang DD, Xu Y, Wu YF, Xia X, Wei W, Hu B.
    Clin Chim Acta; 2017 Aug; 471():76-80. PubMed ID: 28526535
    [Abstract] [Full Text] [Related]

  • 7. Do cytokines correlate with refractory Kawasaki disease in children?
    Wang Y, Qian SY, Yuan Y, Wang Q, Gao L, Chen X, Yu X, Zhen Z.
    Clin Chim Acta; 2020 Jul; 506():222-227. PubMed ID: 32156603
    [Abstract] [Full Text] [Related]

  • 8. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH.
    PLoS One; 2015 Jul; 10(12):e0144603. PubMed ID: 26658843
    [Abstract] [Full Text] [Related]

  • 9. [Expression of interleukin-17A in serum of children with intravenous immunoglobulin-resistant Kawasaki disease and its clinical significance].
    Li SY, Ding Y.
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Mar 15; 25(3):244-249. PubMed ID: 36946157
    [Abstract] [Full Text] [Related]

  • 10. The effects of glucocorticoid plus intravenous immunoglobulin (IVIG) vs IVIG alone on platelet activation in children with Kawasaki disease.
    Wang QQ, Zheng LY, Zhao S.
    Turk J Pediatr; 2023 Mar 15; 65(4):640-649. PubMed ID: 37661679
    [Abstract] [Full Text] [Related]

  • 11. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
    Qin LJ, Wang HW, Hu XF, Liu QJ, Shi H, Wei YX, Chen QJ, Cheng PX.
    Zhonghua Er Ke Za Zhi; 2006 Dec 15; 44(12):891-5. PubMed ID: 17254453
    [Abstract] [Full Text] [Related]

  • 12. Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment.
    Gupta M, Noel GJ, Schaefer M, Friedman D, Bussel J, Johann-Liang R.
    J Clin Immunol; 2001 May 15; 21(3):193-9. PubMed ID: 11403226
    [Abstract] [Full Text] [Related]

  • 13. [Serum levels of interleukin-38 and interleukin-1β in the acute phase of Kawasaki disease in children].
    Zhang XY, He T, Ling JY, Hu XF, Wen Y, Wei J, Lu HL.
    Zhongguo Dang Dai Er Ke Za Zhi; 2018 Jul 15; 20(7):543-548. PubMed ID: 30022755
    [Abstract] [Full Text] [Related]

  • 14. Value of C-reactive protein/albumin ratio in predicting intravenous immunoglobulin-resistant Kawasaki disease- a data from multi-institutional study in China.
    Li G, Wang T, Gou Y, Zeng R, Liu D, Duan Y, Liu B.
    Int Immunopharmacol; 2020 Dec 15; 89(Pt A):107037. PubMed ID: 33242833
    [Abstract] [Full Text] [Related]

  • 15. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
    Sato S, Kawashima H, Kashiwagi Y, Hoshika A.
    Int J Rheum Dis; 2013 Apr 15; 16(2):168-72. PubMed ID: 23773640
    [Abstract] [Full Text] [Related]

  • 16. Intravenous Immunoglobulin Gamma (IVIG) versus IVIG Plus Infliximab in Young Children with Kawasaki Disease.
    Han CL, Zhao SL.
    Med Sci Monit; 2018 Oct 11; 24():7264-7270. PubMed ID: 30307902
    [Abstract] [Full Text] [Related]

  • 17. [A retrospective analysis of 602 Kawasaki disease cases with electronic data capture system].
    Xie L, Zhou C, Wang R, Xiao T, Shen J, Huang M.
    Zhonghua Er Ke Za Zhi; 2015 Jan 11; 53(1):34-9. PubMed ID: 25748402
    [Abstract] [Full Text] [Related]

  • 18. Circulating platelet-neutrophil aggregates play a significant role in Kawasaki disease.
    Ueno K, Nomura Y, Morita Y, Eguchi T, Masuda K, Kawano Y.
    Circ J; 2015 Jan 11; 79(6):1349-56. PubMed ID: 25787672
    [Abstract] [Full Text] [Related]

  • 19. Serum levels of C1q/tumor necrosis factor-related protein-1 in children with Kawasaki disease.
    Feng S, Su Y, Luo L, Jing F, Yi Q.
    Pediatr Res; 2018 May 11; 83(5):999-1003. PubMed ID: 29360808
    [Abstract] [Full Text] [Related]

  • 20. Retrospective study of the course, treatment and long-term follow-up of Kawasaki disease: a single-center experience from Poland.
    Stasiak A, Smolewska E.
    Rheumatol Int; 2019 Jun 11; 39(6):1069-1076. PubMed ID: 30903369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.